Role of Rap1B and tumor suppressor PTEN in the negative regulation of lysophosphatidic acid - Induced migration by isoproterenol in glioma cells

Molecular Biology of the Cell

Volumn 20, Issue 24, 2009, Pages 5156-5165

  Malchinkhuu, Enkhzol ^a   Sato, Koichi ^a   Maehama, Tomohiko ^b   Ishiuchi, Shogo ^c   Yoshimoto, Yuhei ^c   Mogi, Chihiro ^a   Kimura, Takao ^a   Kurose, Hitoshi ^d   Tomura, Hideaki ^a   Okajima, Fumikazu ^a  

^a GUNMA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE RAP1B; ISOPRENALINE; LYSOPHOSPHATIDIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; RAC PROTEIN; RAC1 PROTEIN; RHO FACTOR; SMALL INTERFERING RNA; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1 PHOSPHATE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DOMINANT GENE; DOWN REGULATION; ENZYME ACTIVITY; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; WESTERN BLOTTING;

CELL MOVEMENT; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; GLIOMA; HUMANS; ISOPROTERENOL; LYSOPHOSPHOLIPIDS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RAC1 GTP-BINDING PROTEIN; RAP GTP-BINDING PROTEINS; SPHINGOSINE;

EID: 73849133645     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-08-0692     Document Type: Article

References (50)

1. q, and Gβγ for endothelin-1-induced c-Jun NH2-terminal kinase and extracellular signal-regulated kinase activation. Mol. Pharmacol. 63, 478-488.
2. 2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem. 278, 32841-32851.
3. Burridge, K., and Wennerberg, K. (2004). Rho and Rac take center stage. Cell 116, 167-179.
4. Chandrasekar, N., Mohanam, S., Lakka, S. S., Dinh, D. H., Olivero, W. C., Gujrati, M., and Rao, J. S. (2003). Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signaling. Clin. Cancer Res. 9, 2342-2349.
5. Christian, S. L., Lee, R. L., McLeod, S. J., Burgess, A. E., Li, A. H., Dang-Lawson, M., Lin, K. B., and Gold, M. R. (2003). Activation of the Rap GTPases in B lymphocytes modulates B cell antigen receptor-induced activation of Akt but has no effect on MAPK activation. J. Biol. Chem. 278, 41756-41767.
6. DeAngelis, L. M. (2001). Brain tumors. N. Engl. J. Med. 344, 114-123.
7. de Rooij, J., Zwartkruis, F. J., Verheijen, M. H., Cool, R. H., Nijman, S. M., Wittinghofer, A., and Bos, J. L. (1998). Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396, 474-477.
8. Enserink, J. M., Christensen, A. E., de Rooij, J., van Triest, M., Schwede, F., Genieser, H. G., Doskeland, S. O., Blank, J. L., and Bos, J. L. (2002). A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 4, 901-906.
9. Fukuhara, S., Sakurai, A., Sano, H., Yamagishi, A., Somekawa, S., Takakura, N., Saito, Y., Kangawa, K., and Mochizuki, N. (2005). Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol. Cell. Biol. 25, 136-146.
10. Furman, M. A., and Shulman, K. (1977). Cyclic AMP and adenyl cyclase in brain tumors. J. Neurosurg. 46, 477-483.
11. Gutmann, D. H., Saporito-Irwin, S., DeClue, J. E., Wienecke, R., and Guha, A. (1997). Alterations in the rap1 signaling pathway are common in human gliomas. Oncogene 15, 1611-1616.
12. Howe, A. K. (2004). Regulation of actin-based cell migration by cAMP/PKA. Biochim. Biophys. Acta 1692, 159-174.
13. Howe, A. K., Baldor, L. C., and Hogan, B. P. (2005). Spatial regulation of the cAMP-dependent protein kinase during chemotactic cell migration. Proc. Natl. Acad. Sci. USA 102, 14320-14325.
14. Imamura, F., Horai, T., Mukai, M., Shinkai, K., Sawada, M., and Akedo, H. (1993). Induction of in vitro tumor cell invasion of cellular monolayers by lysophosphatidic acid or phospholipase D. Biochem. Biophys. Res. Commun. 193, 497-503.
15. 2+-permeable AMPA receptors suppresses migration and induces apoptosis in human glioblastoma cells. Nat. Med. 8, 971-978.
16. Kawasaki, H., Springett, G. M., Mochizuki, N., Toki, S., Nakaya, M., Matsuda, M., Housman, D. E., and Graybiel, A. M. (1998). A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279.
17. Kishi, Y., Okudaira, S., Tanaka, M., Hama, K., Shida, D., Kitayama, J., Yamori, T., Aoki, J., Fujimaki, T., and Arai, H. (2006). Autotaxin is overexpressed in glioblastoma multiforme and contributes to cell motility of glioblastoma by converting lysophosphatidylcholine to lysophosphatidic acid. J. Biol. Chem. 281, 17492-17500.
18. 2 inhibits fibroblast chemotaxis. Am. J. Physiol. Lung Cell. Mol. Physiol. 281, L1257-L1263.
19. Kon, J., et al. (1999). Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J. Biol. Chem. 274, 23940-23947.
20. Koul, D., et al. (2001). Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN. Oncogene 20, 6669-6678.
21. Lepley, D., Paik, J. H., Hla, T., and Ferrer, F. (2005). The G protein-coupled receptor S1P2 regulates Rho/Rho kinase pathway to inhibit tumor cell migration. Cancer Res. 65, 3788-3795.
22. Li, J., et al. (1997). PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943-1947.
23. Li, Y., Yin, W., Wang, X., Zhu, W., Huang, Y., and Yan, G. (2007). Cholera toxin induces malignant glioma cell differentiation via the PKA/CREB pathway. Proc. Natl. Acad. Sci. USA 104, 13438-13443.
24. Maehama, T., and Dixon, J. E. (1998). The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375-13378.
25. Malchinkhuu, E., Sato, K., Horiuchi, Y., Mogi, C., Ohwada, S., Ishiuchi, S., Saito, N., Kurose, H., Tomura, H., and Okajima, F. (2005). Role of p38 mitogen-activated kinase and c-Jun terminal kinase in migration response to lysophosphatidic acid and sphingosine-1-phosphate in glioma cells. Oncogene 24, 6676-6688.
26. Malchinkhuu, E., Sato, K., Maehama, T., Mogi, C., Tomura, H., Ishiuchi, S., Yoshimoto, Y., Kurose, H., and Okajima, F. (2008). S1P2 receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN. Biochem. Biophys. Res. Commun. 366, 963-968.
27. Morisco, C., Condorelli, G., Trimarco, V., Bellis, A., Marrone, C., Sadoshima, J., and Trimarco, B. (2005). Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ. Res. 96, 180-188.
28. Ohba, Y., Kurokawa, K., and Matsuda, M. (2003). Mechanism of the spatiotemporal regulation of Ras and Rap1. EMBO J. 22, 859-869.
29. Ohta, H., et al. (2003). Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors. Mol. Pharmacol. 64, 994-1005.
30. Okada, T., Sakuma, L., Fukui, Y., Hazeki, O., and Ui, M. (1994). Blockage of chemotactic peptide-induced stimulation of neutrophils by wortmannin as a result of selective inhibition of phosphatidylinositol 3-kinase. J. Biol. Chem. 269, 3563-3567.
31. Ono, H., Ichiki, T., Fukuyama, K., Iino, N., Masuda, S., Egashira, K., and Takeshita, A. (2004). cAMP-response element-binding protein mediates tumor necrosis factor-alpha-induced vascular smooth muscle cell migration. Arterioscler. Thromb. Vasc. Biol. 24, 1634-1639.
32. Raftopoulou, M., Etienne-Manneville, S., Self, A., Nicholls, S., and Hall, A. (2004). Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Science 303, 1179-1181.
33. Rangarajan, S., Enserink, J. M., Kuiperij, H. B., de Rooij, J., Price, L. S., Schwede, F., and Bos, J. L. (2003). Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor. J. Cell Biol. 160, 487-493.
34. Rasheed, B. K., Stenzel, T. T., McLendon, R. E., Parsons, R., Friedman, A. H., Friedman, H. S., Bigner, D. D., and Bigner, S. H. (1997). PTEN gene mutations are seen in high-grade but not in low-grade gliomas. Cancer Res. 57, 4187-4190.
35. Sanchez, T., Thangada, S., Wu, M. T., Kontos, C. D., Wu, D., Wu, H., and Hla, T. (2005). PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc. Natl. Acad. Sci. USA 102, 4312-4317.
36. Sano, T., et al. (1999). Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res. 59, 1820-1824.
37. Sato, K., et al. (2005). Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources. J. Neurochem. 92, 904-914.
38. Schmid, A. C., Byrne, R. D., Vilar, R., and Woscholski, R. (2004). Bisperox-ovanadium compounds are potent PTEN inhibitors. FEBS Lett. 566, 35-38.
39. Stam, J. C., Michiels, F., van der Kammen, R. A., Moolenaar, W. H., and Collard, J. G. (1998). Invasion of T-lymphoma cells: cooperation between Rho family GTPases and lysophospholipid receptor signaling. EMBO J. 17, 4066-4074.
40. i pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol. Cell. Biol. 23, 1534-1545.
41. Tamura, M., Gu, J., Takino, T., and Yamada, K. M. (1999). Tumor suppressor PTEN inhibition of cell invasion, migration, and growth: differential involvement of focal adhesion kinase and p130Cas. Cancer Res. 59, 442-449.
42. Tokumura, A., Majima, E., Kariya, Y., Tominaga, K., Kogure, K., Yasuda, K., and Fukuzawa, K. (2002). Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase. J. Biol. Chem. 277, 39436-39442.
43. Tsygankova, O. M., Saavedra, A., Rebhun, J. F., Quilliam, L. A., and Meinkoth, J. L. (2001). Coordinated regulation of Rap1 and thyroid differentiation by cyclic AMP and protein kinase A. Mol. Cell. Biol. 21, 1921-1929.
44. Umezu-Goto, M., et al. (2002). Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J. Cell Biol. 158, 227-233.
45. Valles, A. M., Beuvin, M., and Boyer, B. (2004). Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J. Biol. Chem. 279, 44490-44496.
46. Van Brocklyn, J. R., Young, N., and Roof, R. (2003). Sphingosine-1- phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett. 199, 53-60.
47. 1 receptors through the guanine nucleotide exchange factor Tiam1. J. Biol. Chem. 278, 400-406.
48. 2 inhibits fibroblast migration by E-prostanoid 2 receptor-mediated increase in PTEN activity. Am. J. Respir. Cell. Mol. Biol. 32, 135-141.
49. 1. J. Biol. Chem. 279, 6595-6605.
50. Yang, L., Jackson, E., Woerner, B. M., Perry, A., Piwnica-Worms, D., and Rubin, J. B. (2007). Blocking CXCR4-mediated cyclic AMP suppression inhibits brain tumor growth in vivo. Cancer Res. 67, 651-658.